The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Molecular mechanisms and clinical applications of angiogenesis
Open accessAbstract
Blood vessels deliver oxygen and nutrients to every part of the body, but also nourish diseases such as cancer. Over the past decade, our understanding of the molecular mechanisms of angiogenesis (blood vessel growth) has increased at an explosive rate and has led to the approval of anti-angiogenic drugs for cancer and eye diseases. So far, hundreds of thousands of patients have benefited from blockers of the angiogenic protein vascular endothelial growth factor, but limited efficacy and resistance remain outstanding problems. Recent preclinical and clinical studies have shown new molecular targets and principles, which may provide avenues for improving the therapeutic benefit from anti-angiogenic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In clinical settings, this approach has been proven to be ineffective when used alone [23].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [23]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to increasing drug resistance, a high SS could influence tumor cells' gene expression, comprise immune cells ability to kill cancerous cells or even turn macrophages to tumorfriendly cells, thereby enhancing the metastatic potential of cancer cells [180-184].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [184]
Experimental — accuracy not yet measuredIn the citing paper
“This disparity is, in part, attributed to VEGF-independent nonangiogenic mechanisms of vascularization (such as vessel co-option) that are exploited by cancer cells at the early stages of metastasis formation6,9,55,56”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [9]
In the citing paper
“Several cellular and molecular mechanisms of escape from antiangiogenic therapies have been postulated and investigated, including activation of alternative angiogenic pathways, recruitment of proangiogenic myeloid cells, increased pericyte cell coverage of tumour blood vessels, increased tumour cell invasion, and alternative modes of vessel recruitment7,9,80”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Tumour vessels become abnormal in almost all aspects of their structure and functio”
BackgroundSelf-citationAngiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,379
Self-citationIntegrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2748 · Cited by 3,815
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,551
Self-citationVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 1×
“Aberrant FGF signalling promotes tumour angiogenesis and mediates the escape of tumour vascularization from VEGF- or epidermal growth factor receptor (EGFR)-inhibitor treatmen”
BackgroundMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,594
Self-citationHypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
Cited by
Sorted by citations
Items 401–500 of 1,021
Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery
Stapleton, S., Jaffray, D. A., & Milosevic, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.021 · Cited by 158
Design of nanocarriers based on complex biological barriers in vivo for tumor therapy
Liu, J., Li, M., Luo, Z. Y., Dai, L., Guo, X., & Cai, K. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.010 · Cited by 158
The endothelial tip-stalk cell selection and shuffling during angiogenesis
Chen, W., Xia, P., Wang, H., Tu, J., Liang, X., Zhang, X., & Li, L. (2019) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-019-00511-z · Cited by 157
Angiogenesis and Fibrogenesis in Chronic Liver Diseases
Bocca, C., Novo, E., Miglietta, A., & Parola, M. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.06.011 · Cited by 157
Tissue engineering strategies for the induction of angiogenesis using biomaterials
Saberianpour, S., Heidarzadeh, M., Geranmayeh, M. H., Hosseinkhani, H., Rahbarghazi, R., & Nouri, M. (2018) · Journal of Biological Engineering · doi:10.1186/s13036-018-0133-4 · Cited by 157
Micro-CT Imaging of Tumor Angiogenesis
Ehling, J., Theek, B., Gremse, F., Baetke, S. C., Möckel, D., Maynard, J., Ricketts, S., Grüll, H., Neeman, M., Knuechel, R., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.10.014 · Cited by 156
Li, Z., Qu, T., Ding, C., Ma, C., Sun, H., Li, S., & Liu, X. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.11.002 · Cited by 156
The complex mural cell: Pericyte function in health and disease
Dijk, C. V., Nieuweboer, F. E., Pei, J. Y., Xu, Y. J., Bürgisser, P. E., van Mulligen, E., el Azzouzi, H., Duncker, D. J., Verhaar, M. C., & Cheng, C. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.258 · Cited by 156
Bioengineering methods for vascularizing organoids
Nwokoye, P. N., & Abilez, O. J. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100779 · Cited by 156
Griffioen, A. W., Mans, L. A., de Graaf, A. M. A., Nowak-Sliwinska, P. M., de Hoog, C. L. M. M., de Jong, T. A. M., Vyth‐Dreese, F. A., B, J. R. V. B., Bex, A., & Jonasch, E. W. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0002 · Cited by 155
In Vitro Microfluidic Models for Neurodegenerative Disorders
Osaki, T., Shin, Y., Sivathanu, V., Campisi, M., & Kamm, R. D. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700489 · Cited by 155
Wend, S., Kubesch, A., Orłowska, A., Al‐Maawi, S., Zender, N., Dias, A., Miron, R. J., Sader, R., Booms, P., Kirkpatrick, C. J., et al. (2017) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-017-5992-6 · Cited by 155
Targeting Angiogenesis in Prostate Cancer
Melegh, Z., & Oltean, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112676 · Cited by 155
Cathepsin S (CTSS) activity in health and disease - A treasure trove of untapped clinical potential
Smyth, P., Sasiwachirangkul, J., Williams, R. D., & Scott, C. J. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101106 · Cited by 155
Machado, V., Peixoto, D., Costa, R., Froufe, H. J. C., Calhelha, R. C., Abreu, R. M. V., Ferreira, I. C. F. R., Soares, R. A., & Queiroz, M. J. R. P. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.08.010 · Cited by 154
A short discourse on vascular tissue engineering
Chang, W., & Niklason, L. E. (2017) · npj Regenerative Medicine · doi:10.1038/s41536-017-0011-6 · Cited by 154
A Novel Strategy to Engineer Pre-Vascularized Full-Length Dental Pulp-like Tissue Constructs
Athirasala, A., Lins, F. F., Tahayeri, A., Hinds, M. T., Smith, A. J., Sedgley, C., Ferracane, J. L., & Bertassoni, L. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-02532-3 · Cited by 154
Kodack, D. P., Chung, E., Yamashita, H., Incio, J., Duyverman, A. M. M. J., Song, Y., Farrar, C. T., Huang, Y., Ager, E., Kamoun, W., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216078109 · Cited by 153
Self-citationHydrogels to model 3D in vitro microenvironment of tumor vascularization
Song, H.-H. G., Park, K. M., & Gerecht, S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.06.002 · Cited by 153
Adapala, R. K., Thoppil, R. J., Ghosh, K., Cappelli, H. C., Dudley, A. C., Paruchuri, S., Keshamouni, V, Klagsbrun, M., Meszaros, J. G., Chilian, W. M., et al. (2016) · Oncogene · doi:10.1038/onc.2015.83 · Cited by 153
Siveen, K. S., Ahn, K. S., Ong, T. H., Shanmugam, M. K., Li, F., Yap, W. N., Kumar, A. P., Fong, C. W., Tergaonkar, V., Hui, K. M., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1876 · Cited by 153
Role and Regulation of Vascularization Processes in Endochondral Bones
Maes, C. (2013) · Calcified Tissue International · doi:10.1007/s00223-012-9689-z · Cited by 153
Anti-angiogenic treatment strategies for the therapy of endometriosis
Laschke, M. W., & Menger, M. D. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms026 · Cited by 153
A Role for the Long Noncoding RNA SENCR in Commitment and Function of Endothelial Cells
Boulberdaa, M., Scott, E., Ballantyne, M. D., García, R., Descamps, B., Angelini, G. D., Brittan, M., Hunter, A., McBride, M., McClure, J., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.41 · Cited by 153
Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration
Jaffe, G. J., Ciulla, T. A., Ciardella, A. P., Devin, F., Dugel, P. U., Eandi, C. M., Masonson, H., Monés, J., Pearlman, J. A., Maftouhi, M. Q.-E., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.10.010 · Cited by 153
Pathological neoangiogenesis depends on oxidative stress regulation by ATM
Okuno, Y., Nakamura-Ishizu, A., Otsu, K., Suda, T., & Kubota, Y. (2012) · Nature Medicine · doi:10.1038/nm.2846 · Cited by 152
Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery
Zhang, B., Hu, Y., & Pang, Z. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00952 · Cited by 152
Sacchi, V., Mittermayr, R., Hartinger, J., Martino, M. M., Lorentz, K. M., Wolbank, S., Hofmann, A. T., Largo, R. A., Marschall, J. S., Groppa, E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404605111 · Cited by 152
Development of the Renal Arterioles
Sequeira-Lόpez, M. L. S., & Gómez, R. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011080818 · Cited by 152
The Endothelium as a Driver of Liver Fibrosis and Regeneration
Lafoz, E., Ruart, M., Anton, A., Oncins, A., & Hernández–Gea, V. (2020) · Cells · doi:10.3390/cells9040929 · Cited by 152
Garnier, D., Magnus, N., Lee, T. H., Bentley, V. L., Meehan, B., Milsom, C., Montermini, L., Kislinger, T., & Rak, J. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.401760 · Cited by 151
The SDF-1/CXCR4 axis in stem cell preconditioning
Cencioni, C., Capogrossi, M. C., & Napolitano, M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs132 · Cited by 150
Monotherapy and Combination Therapy Using Anti‐Angiogenic Nanoagents to Fight Cancer
Liang, P., Ballou, B. T., Lv, X., Si, W., Bruchez, M. P., Huang, W., & Dong, X. (2021) · Advanced Materials · doi:10.1002/adma.202005155 · Cited by 150
Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications
Darweesh, R. S., Ayoub, N. M., & Nazzal, S. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s223941 · Cited by 149
Intratumoral Myeloid Cells Regulate Responsiveness and Resistance to Antiangiogenic Therapy
Rivera, L. B., Meyronet, D., Hervieu, V., Frederick, M. J., Bergsland, E. K., & Bergers, G. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.055 · Cited by 148
Lin, S., Zhang, Q., Shao, X., Zhang, T., Xue, C., Shi, S., Zhao, D., & Lin, Y. (2017) · Cell Proliferation · doi:10.1111/cpr.12390 · Cited by 148
Sox17 is required for endothelial regeneration following inflammation-induced vascular injury
Liu, M., Zhang, L., Marsboom, G., Jambusaria, A., Xiong, S., Tóth, P. T., Benevolenskaya, E. V., Rehman, J., & Malik, A. B. (2019) · Nature Communications · doi:10.1038/s41467-019-10134-y · Cited by 148
Bovy, N., Blomme, B., Frères, P., Dederen, S., Nivelles, O., Lion, M., Carnet, O., Martial, J. A., Noël, A., Thiry, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3520 · Cited by 147
Ramachandran, L., Manu, K. A., Shanmugam, M. K., Feng, L., Siveen, K. S., Vali, S., Kapoor, S., Abbasi, T., Surana, R., Smoot, D. T., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.388702 · Cited by 147
Cheng, S., Zhang, X., Feng, Q., Chen, J., Shen, L., Yu, P., Yang, L., Chen, D., Zhang, H., Sun, W., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.040 · Cited by 147
Neurogenesis After Stroke: A Therapeutic Perspective
Rahman, A. A., Amruta, N., Pinteaux, E., & Bix, G. J. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00841-w · Cited by 147
Tokatlian, T., Cam, C., & Segura, T. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201400783 · Cited by 146
The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology
Krist, B., Florczyk, U., Pietraszek‐Gremplewicz, K., Józkowicz, A., & Dulak, J. (2015) · International Journal of Endocrinology · doi:10.1155/2015/281756 · Cited by 146
In situ prevascularization designed by laser-assisted bioprinting: effect on bone regeneration
Kérourédan, O., Hakobyan, D., Rémy, M., Ziane, S., Dusserre, N., Fricain, J., Delmond, S., Thébaud, N., & Devillard, R. (2019) · Biofabrication · doi:10.1088/1758-5090/ab2620 · Cited by 145
Chen, B., Gao, A., Tu, B., Wang, Y., Yu, X., Wang, Y., Xiu, Y., Wang, B., Wan, Y., & Huang, Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120187 · Cited by 145
Ding, R., Hase, Y., Ameen‐Ali, K. E., Ndung'u, M., Stevenson, W., Barsby, J., Gourlay, R., Akinyemi, T. O., Akinyemi, R., Uemura, M. T., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12888 · Cited by 145
Tracing the genetic footprints of vertebrate landing in non-teleost ray-finned fishes
Bi, X., Wang, K., Yang, L., Pan, H., Jiang, H., Wei, Q., Fang, M., Yu, H., Zhu, C., Cai, Y., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.046 · Cited by 145
Gao, D.-Y., Lin, T.-T., Sung, Y., Liu, Y. C., Chiang, W., Chang, C.-C., Liu, J., & Chen, Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.035 · Cited by 144
Li, P., Guo, W., Du, L., Zhao, J., Wang, Y., Liu, L., Hu, Y., & Hou, Y. (2012) · Clinical Science · doi:10.1042/cs20120121 · Cited by 144
Plant triterpenoid saponins: biosynthesis, in vitro production, and pharmacological relevance
Biswas, T., & Dwivedi, U. N. (2019) · PROTOPLASMA · doi:10.1007/s00709-019-01411-0 · Cited by 144
Post-stroke remodeling processes in animal models and humans
Cirillo, C., Brihmat, N., Castel-Lacanal, E., Friec, A. L., Barbieux‐Guillot, M., Raposo, N., Pariente, J., Viguier, A., Simonetta‐Moreau, M., Albucher, J., et al. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19882788 · Cited by 144
Draoui, N., de Zeeuw, P., & Carmeliet, P. (2017) · Open Biology · doi:10.1098/rsob.170219 · Cited by 143
Self-citationLeuning, D. G., Beijer, N. R. M., du Fossé, N. A., Vermeulen, S., Lievers, E., van Kooten, C., Rabelink, T. J., & de Boer, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-25700-5 · Cited by 143
Garg, M., Shanmugam, M. K., Bhardwaj, V., Goel, A., Gupta, R., Sharma, A., Baligar, P., Kumar, A. P., Goh, B. C., Wang, L., et al. (2020) · Medicinal Research Reviews · doi:10.1002/med.21761 · Cited by 143
Mantsounga, C., Lee, C. F., Neverson, J., Sharma, S., Healy, A. L., Berus, J. M., Parry, C., Ceneri, N. M., López‐Giráldez, F., Chun, H. J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110309 · Cited by 143
Hill, B. S., Sarnella, A., D’Avino, G., & Zannetti, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.028 · Cited by 142
Ling, Z., Chen, Z., Deng, J. G., Wang, Y., Yuan, B., Yang, X., Lin, H., Cao, J., Zhu, X., & Zhang, X. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.130302 · Cited by 141
The Plasminogen–Activator Plasmin System in Physiological and Pathophysiological Angiogenesis
Ismail, A. A., Shaker, B. T., & Bajou, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010337 · Cited by 141
Ayoub, N. M., Jaradat, S. K., Al-Shami, K. M., & Alkhalifa, A. E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.838133 · Cited by 141
Srivastava, K., Hu, J., Korn, C., Savant, S., Teichert, M., Kapel, S. S., Jugold, M., Besemfelder, E., Thomas, M., Pasparakis, M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.11.005 · Cited by 140
CURRENT KNOWLEDGE AND TRENDS IN AGE-RELATED MACULAR DEGENERATION
Vélez-Montoya, R., Oliver, S. C. N., Olson, J. L., Fine, S. L., Quiroz-Mercado, H., & Mandava, N. (2013) · Retina · doi:10.1097/iae.0000000000000036 · Cited by 141
Jaiswal, R., & Sedger, L. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00125 · Cited by 140
Huang, M., Zhang, D., Wu, J. Y., Xing, K., Yeo, E., Li, C., Zhang, L., Holland, E. C., Yao, L., Qin, L., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay7522 · Cited by 140
The Role of PDGFs and PDGFRs in Colorectal Cancer
Manzat-Saplacan, R. M., Bălăcescu, L., Gherman, C. D., Chira, R. I., Anca, C., Mircea, P. A., Lisencu, C. I., & Bălăcescu, O. (2017) · Mediators of Inflammation · doi:10.1155/2017/4708076 · Cited by 139
Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
Ata, R., & Antonescu, C. N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010189 · Cited by 139
Wang, J.-C., Li, G.-Y., Wang, B., Han, S.-X., Sun, X., Jiang, Y.-N., Shen, Y.-W., Zhou, C., Feng, J., Lu, S.-Y., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1211-2 · Cited by 138
Awada, H. K., Johnson, N. R., & Wang, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.034 · Cited by 138
Jain, R. K., & Carmeliet, P. (2012) · Cell · doi:10.1016/j.cell.2012.05.025 · Cited by 138
Self-citationAger, E. I., Kozin, S. V., Kirkpatrick, N. D., Seano, G., Kodack, D. P., Askoxylakis, V., Huang, Y., Goel, S., Snuderl, M., Muzikansky, A., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv017 · Cited by 138
Self-citationCao, Z., Scandura, J. M., Inghirami, G., Shido, K., Ding, B., & Rafii, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.11.010 · Cited by 138
Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma
Rosenberger, L., Ezquer, M., Lillo-Vera, F., Pedraza, P. L., Ortúzar, M. I., González, P. L., Figueroa‐Valdés, A. I., Cuenca, J., Ezquer, F. E., Khoury, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36855-6 · Cited by 138
Vessel co-option and resistance to anti-angiogenic therapy
Kuczynski, E. A., & Reynolds, A. R. (2019) · Angiogenesis · doi:10.1007/s10456-019-09698-6 · Cited by 138
Kelley, R. K., Verslype, C., Cohn, A. L., Yang, T.-S., Su, W., Burris, H. A., Braiteh, F., Vogelzang, N. J., Spira, A. I., Foster, P., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw651 · Cited by 137
The Warburg Effect in Endothelial Cells and its Potential as an Anti-angiogenic Target in Cancer
Fitzgerald, G., Soro-Arnáiz, I., & Bock, K. D. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00100 · Cited by 137
The metabolic engine of endothelial cells
Falkenberg, K. D., Rohlenová, K., Luo, Y., & Carmeliet, P. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0117-9 · Cited by 137
Self-citationStructural basis of thalidomide enantiomer binding to cereblon
Mori, T., Ito, T., Liu, S., Ando, H., Sakamoto, S., Yamaguchi, Y., Tokunaga, E., Shibata, N., Handa, H., & Hakoshima, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-19202-7 · Cited by 136
Lefere, S., de Velde, F. V., Hoorens, A., Raevens, S., Campenhout, S. V., Vandierendonck, A., Neyt, S., Vandeghinste, B., Vanhove, C., Debbaut, C., et al. (2018) · Hepatology · doi:10.1002/hep.30294 · Cited by 136
The role of glia in retinal vascular disease
Coorey, N. J., Shen, W., Chung, S. H., Zhu, L., & Gillies, M. C. (2012) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.2012.00741.x · Cited by 136
Wälchli, T., Mateos, J. M., Weinmann, O., Babic, D., Regli, L., Hoerstrup, S. P., Gerhardt, H., Schwab, M. E., & Vogel, J. (2014) · Nature Protocols · doi:10.1038/nprot.2015.002 · Cited by 135
Fu, X., Yang, Y., Li, X., Lai, H., Huang, Y., He, L., Zheng, W., & Chen, T. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.01.012 · Cited by 135
Liang, S., Chen, Z., Jiang, G., Zhou, Y., Liu, Q., Su, Q., Wei, W., Du, J., & Wang, H. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.003 · Cited by 134
Biomaterials for Bioprinting Microvasculature
Barrs, R. W., Jia, J., Silver, S. E., Yost, M. J., & Mei, Y. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00027 · Cited by 134
Li, Z., Wu, M., Liu, S., Liu, X., Huan, Y., Ye, Q., Yang, X., Ht, G., Liu, A., Yang, X., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.05.006 · Cited by 134
Antiangiogenic Effect of Flavonoids and Chalcones: An Update
Mirossay, L., Varinská, L., & Mojžíš, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010027 · Cited by 133
Tumor Angiogenesis and Anti-angiogenic Therapy
Kubota, Y. (2012) · The Keio Journal of Medicine · doi:10.2302/kjm.61.47 · Cited by 132
Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption
Kim, C., Yang, H., Fukushima, Y., Saw, P. E., Lee, J., Park, J.-S., Park, I., Jung, J., Kataoka, H., Lee, D., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.010 · Cited by 131
Martínez‐González, A., Calvo, G. F., Pérez-Romasanta, L. A., & Pérez‐García, V. M. (2012) · Bulletin of Mathematical Biology · doi:10.1007/s11538-012-9786-1 · Cited by 131
Raimondi, C., Fantin, A., Λαμπροπούλου, Α., Denti, L., Chikh, A., & Ruhrberg, C. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20132330 · Cited by 131
miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
Hu, Y., Qiu, Y., Yagüe, E., Ji, W., Liu, J., & Zhang, J. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.194 · Cited by 131
New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer
Zhang, Y., Yang, S.-H., & Guo, X. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.041 · Cited by 130
Intelligent Vascularized 3D/4D/5D/6D-Printed Tissue Scaffolds
Han, X., Saiding, Q., Cai, X., Xiao, Y., Wang, P., Cai, Z., Gong, X., Gong, W., Zhang, X., & Cui, W. (2023) · Nano-Micro Letters · doi:10.1007/s40820-023-01187-2 · Cited by 130
Saghiri, M. A., Asatourian, A., Sorenson, C. M., & Sheibani, N. (2015) · Journal of Endodontics · doi:10.1016/j.joen.2014.12.019 · Cited by 129
The role of hypoxia‐inducible factor‐2 alpha in angiogenesis
Befani, C. D., & Liakos, P. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26805 · Cited by 129
Role of METTL3-Dependent N6-Methyladenosine mRNA Modification in the Promotion of Angiogenesis
Yao, M., Jiang, Q., Ma, Y., Liu, C., Zhu, C.-Y., Sun, Y., Shan, K. Y., Ge, H., Zhang, Q., Zhang, H., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.07.022 · Cited by 129
The role of endothelial cell–pericyte interactions in vascularization and diseases
Li, G., Gao, J., Ding, P., & Gao, Y. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.01.016 · Cited by 129
Shim, J., Oh, S. J., Yeo, E., Park, J., Bae, J. H., Kim, S., Lee, D., & Lee, J. H. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.01.017 · Cited by 128
Pauty, J., Usuba, R., Cheng, I. G., Hespel, L., Takahashi, H., Kato, K., Kobayashi, M., Nakajima, H., Lee, E., Yger, F., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.12.014 · Cited by 127
Matrix Metalloproteinases’ Role in Tumor Microenvironment
González-Ávila, G., Sommer, B., García-Hernández, A. A., & Ramos, C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-40146-7_5 · Cited by 127
The role of bone morphogenetic protein signaling in vascular calcification
Yang, P. B., Troncone, L., Augur, Z. M., Kim, S. S., McNeil, M. E., & Yu, P. B. (2020) · Bone · doi:10.1016/j.bone.2020.115542 · Cited by 127
Heist, R. S., Duda, D. G., Sahani, D. V., Ancukiewicz, M., Fidias, P., Sequist, L. V., Temel, J. S., Shaw, A. T., Pennell, N. A., Neal, J. W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424024112 · Cited by 126
Self-citation
Metadata
- Authors
- Carmeliet, P., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Carmeliet, Peter
- Jain, Rakesh K.
- ORCID
- Carmeliet, Peter
- Venue
- Nature
- Published
- 2011-05
- Volume
- 473
- Issue
- 7347
- Pages
- 298-307
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4049445
- OpenAlex
- W1992112921
- Semantic Scholar
- cc1723f25e863386b91340ea03cd76a22de359ae
- Cited by
- 5,467
- References
- 100
- Citations by year
- 2026: 238 · 2025: 316 · 2024: 308 · 2023: 364 · 2022: 393 · 2021: 442 · 2020: 399 · 2019: 399 · 2018: 384 · 2017: 454 · 2016: 369 · 2015: 375 · 2014: 326 · 2013: 342 · 2012: 284
- FWCI
- 29.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA115767, R01CA085140, P01CA080124, R01CA126642, R01CA163815)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Vascular Tumors and Angiosarcomas
- Keywords
- angiogenesis, angiogenesis inhibitors, vascular endothelial growth factor, VEGF inhibitors, drug resistance, molecular targets, cancer, eye diseases, blood vessel development
- MeSH terms
- Animals, Blood Vessels, Fibroblast Growth Factors, Humans, Platelet-Derived Growth Factor, Transforming Growth Factor beta, Neovascularization, Physiologic, Angiogenesis Inhibitors, Vesicular Transport Proteins, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
